.Knowledge Therapeutics' stage 2 sparkle trial has actually taken a number of the gloss off the Alzh...
.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, stopp...
.Charles Baum, M.D., Ph.D., who oversaw Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers Squ...
.After reaching out to greater than 200 providers to partner a Tourette disorder therapy that presen...
.Novartis has possessed some rotten luck with bispecific antibodies previously, however evaluating d...
.Pinetree Therapies will definitely aid AstraZeneca vegetation some trees in its own pipeline along ...
.GRO Biosciences has actually finished the full week with an extra $60.3 million in the financial in...
.Accept to this week's Chutes & Ladders, our summary of considerable leadership hirings, shooting...